Before you begin reading about tricuspid atresia in children, please read the explanation of how the normal heart works for a basic understanding of its structure and function.
The right side of the normal heart receives oxygen-poor blood (blue blood)
View Large Tricuspid Atresia Illustration from the body’s veins and pumps it to the lungs to receive oxygen. The oxygen-rich blood (red blood) returns from the lungs to the left side of the heart, which pumps the blood to the body. The tricuspid valve is the opening between the right atrium (the upper chamber) and the right ventricle (the lower chamber) A heart with tricuspid atresia is characterized by poorly developed right heart structures and:
Tricuspid atresia in children is often associated with pulmonary stenosis or narrowing of the pulmonary valve. Tricuspid atresia can also be associated with transposition of the great arteries, where the aorta, the large artery that carries blood to the body, arises from the small right ventricle, and the pulmonary artery (lung artery) arises from the large left ventricle.
Tricuspid atresia is a single-ventricle lesion, because the heart has only one functioning ventricle (the left ventricle).
Tricuspid atresia symptoms in children include:
Tricuspid atresia in children may be diagnosed before birth, with fetal echocardiogram. Our Fetal Heart Program can prepare a plan for delivery and care immediately after birth.
Tricuspid atresia is usually diagnosed a few hours or days after birth. Pediatricians from other hospitals refer newborns to the Cardiac Center when they notice symptoms and signs such as a “blue baby with a heart murmur.” Pulse oximetry is a painless way to monitor the oxygen level of the blood.
Some or all of these tests may be required for diagnosis of tricuspid atresia in children:
Your baby will be admitted to the Tabas Cardiac Intensive Care Unit (CICU). The baby may require oxygen, and a medication called prostaglandin to maintain adequate oxygen level in the blood. Prostaglandin is an intravenous medication that keeps open the connection between the pulmonary artery (the artery that normally carries blue blood to the lungs to receive oxygen) and the aorta (the artery that carries red blood to the body). This connection, called PDA or patent ductus arteriosus, is open in the fetus, and closes soon after birth. When the PDA closes, some babies with tricuspid atresia turn quite blue/cyanosed. An infusion of prostaglandin can re-open the PDA and is a life-saving intervention. Not all babies with tricuspid atresia require prostaglandin.
If the baby has labored breathing or poor effort, he or she may need help with a breathing machine or ventilator. It is not uncommon for babies to have poor respiratory effort or apnea while on prostaglandin infusion.
At least two and possibly three surgeries will be required:
Babies who require prostaglandin to maintain adequate oxygen level will require surgery soon after birth. The surgery involves creation of a “shunt,” which is a tube that connects one of the branches of the aorta and the pulmonary artery, and thus replaces the PDA. This operation is called the Blalock-Taussig shunt or BT shunt. Many babies with tricuspid atresia are well enough to be discharged home soon after birth. However, some of these babies may require the “shunt” operation at a few weeks of life if the level of oxygen in their blood is decreasing.
Some babies with tricuspid atresia are too “pink” or have too much blood-flow to the lungs, and will require an operation called “pulmonary artery banding” to narrow the pulmonary artery and regulate blood flow to the lungs. Babies with tricuspid atresia and transposition of great arteries may require the “Norwood operation” if the aorta is too small (see hypoplastic left heart syndrome).
The second operation, called the hemi-Fontan/Glenn operation usually occurs within six months of birth. During this surgery, the superior vena cava, the large vein attached to the heart to return deoxygenated or blue blood from the upper half of the body, is closed off or disconnected from the heart and attached to the pulmonary artery. During this operation, the surgeon also closes the BT shunt. After this operation, deoxygenated or blue blood from the upper body goes directly to the lungs without passing through the heart.
The third operation, called the Fontan, occurs at approximately 1 1/2 to 3 years of age. During this surgery, blood from the inferior vena cava, the large vein that returns deoxygenated blood to the heart from the lower half of the body, is diverted directly to the pulmonary artery. This means that deoxygenated or blue blood from the whole body goes to the lungs without passing through the heart.
After these operations, deoxygenated blood flows to the lungs without passing through the right side of the heart. The Cardiac Center team will explain the surgical procedures to you in more detail, based on your child’s heart anatomy.
Of historical interest, the Fontan operation was performed for the first time in patients with tricuspid atresia.
Though early outcomes for patients with single ventricle heart defects after staged reconstruction have improved dramatically, the period between the Norwood procedure and the Glenn operation remains a very vulnerable time for infants. CHOP created the Infant Single Ventricle Monitoring Program to focus on the care and monitoring of infants with single ventricle heart defects between the first and second reconstructive surgeries.
Children with tricuspid atresia require life-long care by a cardiologist. Many remain on medications for life. Additional surgeries may be required.
As “single ventricle survivors” get older, doctors are recognizing that, while some do fine, many experience complications, including lung, liver and gastrointestinal diseases. The Cardiac Center at CHOP created the Single Ventricle Survivorship Program to bring together doctors from different specialties to care for single ventricle survivors.
In addition, as a group, children with complex congenital heart defects who have had open heart surgery as infants are at a higher risk for neurodevelopmental issues when compared to children without congenital heart defects. The Cardiac Center at CHOP created the NeuroCardiac Care Program (NCCP) to provide evaluation, screening and clinical care for children with complex congenital heart disease who are at risk for neurodevelopmental problems.
Our pediatric cardiologists follow patients until they are young adults, coordinating care with the primary care physicians.
It’s important that your child continue to see a cardiologist as an adult. We will help with the transition to an adult cardiologist. The Philadelphia Adult Congenital Heart Center, a joint program of The Children’s Hospital of Philadelphia and the University of Pennsylvania, meets the unique needs of adults who were born with heart defects.
Because of enormous strides in medicine and technology, today many children born with tricuspid atresia go on to lead healthy, productive lives as adults.
Contact the Cardiac Center at The Children's Hospital of Philadelphia for a second opinion or for more information.
Reviewed by: Paul Weinberg, MD
Date: May 2013
For a second opinion, cardiac referral, or for more information.
To schedule an outpatient appointment.